BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 28957872)

  • 1. Utility of post-liver transplantation MELD and delta MELD in predicting early and late mortality.
    Zakareya T; Abbasy M; Abdel-Razek W; Elsiesy H; Abal Khail F; Al Sebayel M; Waked I
    Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1424-1427. PubMed ID: 28957872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of postoperative Model for End-Stage Liver Disease scoring system for evaluating liver graft function after living donor liver transplantation.
    Toshima T; Ikegami T; Kimura K; Harimoto N; Yamashita Y; Yoshizumi T; Soejima Y; Ikeda T; Shirabe K; Maehara Y
    Transplant Proc; 2014; 46(1):81-6. PubMed ID: 24507030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of indocyanine green clearance test and model for end-stage liver disease score predicts early graft outcome after liver transplantation.
    Yunhua T; Weiqiang J; Maogen C; Sai Y; Zhiheng Z; Dongping W; Zhiyong G; Xiaoshun H
    J Clin Monit Comput; 2018 Jun; 32(3):471-479. PubMed ID: 28831767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database.
    Rifai G; Anani A; Hanouneh IA; Mohamad B; Matloob A; Lopez R; Zein NN; Alkhouri N
    Transplant Proc; 2016 Dec; 48(10):3362-3367. PubMed ID: 27931582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of Model for End-Stage Liver Disease-Serum Sodium Scores in Predicting Complication Severity Grades After Liver Transplantation for Acute-on-chronic Liver Failure.
    Zhang QK; Wang ML
    Transplant Proc; 2019 Apr; 51(3):833-841. PubMed ID: 30979472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting early allograft failure and mortality after liver transplantation: the role of the postoperative model for end-stage liver disease score.
    Wagener G; Raffel B; Young AT; Minhaz M; Emond J
    Liver Transpl; 2013 May; 19(5):534-42. PubMed ID: 23576469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model for end-stage liver disease score in the first 3 weeks after liver transplantation as a predictor for long-term outcome.
    Khandoga A; Iskandarov E; Angele M; Gerbes A; Frey L; Ağayev B; Jauch KW; Werner J; Guba M
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):153-8. PubMed ID: 26545081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month].
    Bae WK; Lee JS; Kim NH; Kim KA; Moon YS; Oh MK
    Korean J Hepatol; 2007 Mar; 13(1):51-60. PubMed ID: 17380075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired functional capacity in potential liver transplant candidates predicts short-term mortality before transplantation.
    Ow MM; Erasmus P; Minto G; Struthers R; Joseph M; Smith A; Warshow UM; Cramp ME; Cross TJ
    Liver Transpl; 2014 Sep; 20(9):1081-8. PubMed ID: 24805969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal outcomes after liver transplantation in the model for end-stage liver disease era.
    Sharma P; Welch K; Eikstadt R; Marrero JA; Fontana RJ; Lok AS
    Liver Transpl; 2009 Sep; 15(9):1142-8. PubMed ID: 19718633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation.
    Cholongitas E; Marelli L; Shusang V; Senzolo M; Rolles K; Patch D; Burroughs AK
    Liver Transpl; 2006 Jul; 12(7):1049-61. PubMed ID: 16799946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposal of Muscle-MELD Score, Including Muscularity, for Prediction of Mortality After Living Donor Liver Transplantation.
    Hamaguchi Y; Kaido T; Okumura S; Kobayashi A; Shirai H; Yagi S; Hammad A; Okajima H; Uemoto S
    Transplantation; 2016 Nov; 100(11):2416-2423. PubMed ID: 27495765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical usefulness of DeltaMELD to predict the survival of patients with liver cirrhosis].
    Eun SH; Kim YS; Jang JY; Cheon YG; Kim YS; Cho YD; Lee JS; Lee MS; Kim JH; Shim CS; Kim BS
    Korean J Hepatol; 2006 Dec; 12(4):530-8. PubMed ID: 17237631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified model for end-stage liver disease improves short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure.
    Chen W; You J; Chen J; Zheng Q; Jiang JJ; Zhu YY
    World J Gastroenterol; 2017 Oct; 23(40):7303-7309. PubMed ID: 29142477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis.
    Suk KT; Kim CH; Park SH; Sung HT; Choi JY; Han KH; Hong SH; Kim DY; Yoon JH; Kim YS; Baik GH; Kim JB; Kim DJ
    J Clin Gastroenterol; 2012; 46(10):880-6. PubMed ID: 22810110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
    Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
    Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.
    Ikegami T; Imai D; Wang H; Yoshizumi T; Yamashita Y; Ninomiya M; Iguchi T; Bekki Y; Shirabe K; Maehara Y
    Transplantation; 2014 Feb; 97(4):457-62. PubMed ID: 24531822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Model of End-Stage Liver Disease for Liver Transplant Allocation in Alberta: Implications for Future Directions in Canada.
    Burak KW; Meeberg GA; Myers RP; Fick GH; Swain MG; Bain VG; Kneteman NM; Hilsden RJ
    Can J Gastroenterol Hepatol; 2016; 2016():1329532. PubMed ID: 27446823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different Score Systems to Predict Mortality in Living Donor Liver Transplantation: Which Is the Winner? The Experience of an Egyptian Center for Living Donor Liver Transplantation.
    El Amir M; Gamal Eldeen H; Mogawer S; Esmat G; El-Shazly M; El-Garem N; Abdelaziz MS; Salah A; Hosny A
    Transplant Proc; 2015 Dec; 47(10):2897-901. PubMed ID: 26707310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.